| abstract |
[R- (R * , R * )]-2- (4-fluorophenyl) -β, δ-dihydroxy-5- (1-methylethyl) -3-phenyl-4-[(phenylamino) carbonyl]- Novel salt forms of 1H-pyrrole-1-heptanoic acid, or solvates or hydrates thereof, and crystalline salt characterized by their powder X-ray diffraction pattern, and high methods for their preparation and Pharmaceutical compositions are described and are useful as therapeutic agents for hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia, and Alzheimer's disease. |